Johnson Investment Counsel’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53M Buy
55,551
+584
+1% +$19.2K 0.01% 389
2026
Q1
$2.05M Buy
54,967
+829
+2% +$34.2K 0.02% 321
2025
Q4
$2.53M Hold
54,138
– – 0.02% 269
2025
Q3
$2.27M Buy
54,138
+311
+0.6% +$13.7K 0.02% 296
2025
Q2
$2.37M Buy
53,827
+537
+1% +$24.3K 0.02% 270
2025
Q1
$2.68M Sell
53,290
-26,170
-33% -$1.3M 0.03% 237
2024
Q4
$3.41M Hold
79,460
– – 0.03% 200
2024
Q3
$3.12M Buy
79,460
+13,630
+21% +$493K 0.03% 220
2024
Q2
$2.12M Buy
65,830
+18,540
+39% +$598K 0.02% 264
2024
Q1
$1.56M Buy
47,290
+2,800
+6% +$97.3K 0.02% 313
2023
Q4
$1.54M Sell
44,490
-2,800
-6% -$96.6K 0.02% 300
2023
Q3
$1.71M Buy
47,290
+400
+0.9% +$14.9K 0.02% 269
2023
Q2
$1.76M Buy
+46,890
New +$1.89M 0.02% 268

Other funds holding G

Johnson Investment Counsel's G Position: Q2 2026 in Review

Johnson Investment Counsel increased its Genpact (G) stake by 1.1% in Q2 2026, buying an estimated $19.2K and bringing the position to 55,551 shares worth $1.53M. The position accounts for 0.01% of the portfolio, ranked #389.

Johnson Investment Counsel first reported a position in G in Q2 2023 and has held it in 13 quarters since. The position peaked at $3.41M in Q4 2024. 479 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • Johnson Investment Counsel held 55,551 shares of Genpact worth $1.53M as of Q2 2026.
  • Johnson Investment Counsel bought 584 Genpact shares in Q2 2026, an estimated $19.2K.
  • Genpact made up 0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #389 holding.
  • Johnson Investment Counsel first reported a position in Genpact in Q2 2023 and has held it in 13 quarters since.
  • Johnson Investment Counsel's Genpact position peaked at $3.41M in Q4 2024.
  • 479 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.